Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes
Moglie Le Quintrec1, Lubka Roumenina, Marina Noris
1Service de Néphrologie, Hôpital Foch, 40 rue Worth, Suresnes, Paris, France.
Seminars in Thrombosis and Hemostasis
|September 25, 2010
Summary
Atypical hemolytic uremic syndrome (aHUS) knowledge has grown, but early symptom recognition is crucial. Genetic insights into complement regulatory genes are improving patient management strategies for this severe disorder.
Area of Science:
- Nephrology
- Genetics
- Immunology
Background:
- Atypical hemolytic uremic syndrome (aHUS) is a severe thrombotic microangiopathy.
- Despite advances, early diagnosis and effective management remain challenging.
- Recent years have seen significant progress in understanding aHUS pathophysiology.
Purpose of the Study:
- To review the advancements in understanding aHUS pathophysiology.
- To highlight the role of genetic abnormalities in complement regulatory genes.
- To discuss the implications for tailored patient management.
Main Methods:
- Literature review of recent studies on aHUS.
- Analysis of genetic data from aHUS patient cohorts.
- Synthesis of current knowledge on disease mechanisms and treatment.
Main Results:
- Substantial increase in knowledge regarding aHUS pathophysiology over the last decade.
- Identification of genetic abnormalities in complement regulatory genes in most aHUS patients.
- Demonstrated influence of specific genetic defects on disease outcomes.
Conclusions:
- Genetic discoveries provide new insights into aHUS pathogenesis.
- Understanding genetic underpinnings enables more personalized treatment approaches.
- Continued research is vital for optimizing the management of aHUS.
Related Concept Videos
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:27Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
02:18Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...